The global phlebotomy equipment market is poised for substantial growth, with sales projected to increase from USD 14,693.1 million in 2025 to USD 21,468.1 million by 2035, reflecting a steady CAGR of 3.9% over the forecast period. In 2024, the market generated a revenue of USD 14,044.3 million, underlining its upward trajectory.
Market Growth Drivers:
- Prevalence of Blood Disorders:
The increasing prevalence of blood disorders, including anemia, hemophilia, leukemia, and thrombocytopenia, is driving demand for phlebotomy equipment. These conditions necessitate regular diagnostic testing, monitoring, and blood sampling, making phlebotomy procedures integral to patient care. With millions of individuals affected globally, the need for accurate and efficient blood collection devices continues to rise.
- Impact of Chronic Diseases:
The growing incidence of diabetes and cardiovascular disorders is contributing to secondary blood abnormalities, further amplifying the demand for phlebotomy procedures. These chronic conditions often require frequent blood tests to assess and manage associated complications, bolstering the market for phlebotomy equipment.
- Cancer-Driven Demand:
The global rise in cancer cases has resulted in increased instances of chemotherapy-associated complications such as leukopenia and anemia. These complications necessitate regular blood collection and analysis, driving the adoption of phlebotomy equipment in oncology care settings.
Future Outlook:
The projected growth in the phlebotomy equipment market underscores its critical role in healthcare diagnostics and disease management. Advances in blood collection technologies, coupled with rising healthcare awareness, are expected to further fuel market expansion.
Key Takeaways: Global Phlebotomy Equipment Market
- Market Valuation:
- Global sales of phlebotomy equipment were USD 14,044.3 million in 2024.
- Estimated to grow to USD 14,693.1 million by 2025 and projected to reach USD 21,468.1 million by 2035.
- Sales are expected to expand at a CAGR of 3.9% between 2025 and 2035.
- Regional Growth Insights:
- United States Forecasted CAGR of 4.0% (2025–2035).
- Germany Expected to grow at a CAGR of 5.1% during the forecast period.
- China Anticipated CAGR of 5.8%, showcasing robust growth potential.
- France Estimated to record a CAGR of 5.5%.
- India Leading with a projected CAGR of 6.3%, indicating significant market expansion.
- Spain Predicted to grow at a CAGR of 4.9%.
- Australia & New Zealand Expected to achieve a CAGR of 5.2%.
- South Korea Anticipated CAGR of 5.9%, highlighting steady progress.
The global phlebotomy equipment market is poised for steady growth, driven by increasing demand across key regions. Notable growth in emerging economies like India and China reflects expanding healthcare infrastructure and rising adoption of advanced medical devices. Developed markets such as the United States, Germany, and France continue to contribute significantly, showcasing consistent growth trends.
“Phlebotomy equipment encompasses a wide range of tools used in blood collection, including needles, syringes, blood collection tubes, and lancets. These devices ensure safe, precise, and efficient blood sampling, which is vital for diagnosing and managing various medical conditions,” says Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI) analyst.
Demand for Market Analysis: Our Comprehensive Report Offers Detailed Trends and Insights!
Competitive Landscape:
Market players are employing strategies like product differentiation through innovative formulations and forming strategic partnerships with healthcare providers for efficient distribution. Additionally, companies are focusing on securing strategic alliances to enhance their product portfolios and strengthen their global market presence.
Recent Developments in the Phlebotomy Equipment Market:
- January 10, 2024: Medline, a leading manufacturer and supplier of medical solutions, completed the acquisition of United Medco, a national provider of supplemental benefits and member engagement solutions. This move significantly strengthens Medline’s Health Plans business, expanding its distribution network and supplemental benefits offerings.
- December 8, 2023: Becton, Dickinson and Company (BD) received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the BD MiniDraw Capillary Blood Collection System, a fingertip blood collection tool designed to enhance precision and convenience in capillary blood collection.
Key Players of Phlebotomy Equipment Market:
- Cardinal Health
- Source-Ray, Inc.
- Becton, Dickinson and Company
- Terumo Medical Corporation
- SARSTEDT AG & Co. KG
- Medline Industries, Inc.
- Vitrex Medical A/S
- F.L. Medical
- Timedico A/S
- Heathrow Scientific LLC
Key Segments of Phlebotomy Equipment Market:
By Product:
In terms of product, the industry is divided into- Phlebotomy supplies, phlebotomy carts, phlebotomy cabinets and phlebotomy chairs and phlebotomy tables.
By Usage:
In terms of usage, the industry is segregated into- disposable devices and reusable devices.
By End User:
In terms of end user, the industry is segregated into- Hospitals, ambulatory surgical centers, diagnostic laboratories, skilled nursing facilities, long term care centers, specialty clinics, blood banks and home healthcare providers and others.
By Region:
Key countries of North America, Latin America, Western Europe, Eastern Europe, South Asia and Pacific, East Asia and Middle East and Africa (MEA) have been covered in the report.
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Explore FMI’s Related Ongoing Coverage on Healthcare Market Insights Domain:
Exhibiting a y-o-y growth of 3.8%, the United States phlebotomy equipment industry revenue is estimated to total USD 4.2 billion in 2024. Demand for phlebotomy equipment in the United States will likely rise at a CAGR of 3.3% throughout the forecast period. By 2034, the United States industry size is set to reach USD 5.8 billion.
The global hearing aids market share is expected to grow between 2024 and 2034 at a CAGR of 2.3%. The market is expected to increase due to the growing geriatric population, the rising incidence of hearing loss, the increasing usage of hearing aids, and the growing awareness of technologically sophisticated devices for auditory impairment. The demand for hearing aids is expected to grow from USD 8.74 billion in 2024 to USD 10.98 billion by 2034.
The global sales of ear health holds a valuation of USD 1.60 Billion by the end of the year 2022. Throughout the forecast period of 2023 to 2033, the market is likely to display growth at a CAGR of 6.4%, and is expected to hold a market value of around USD 3.16 Billion in 2033.
The global home sleep apnea testing market growth are estimated to be worth USD 712.3 million in 2025 and are anticipated to reach a value of USD 966.1 million by 2035. Sales are projected to rise at a CAGR of 3.1% over the forecast period between 2025 and 2035.
The global surgical booms market demand is estimated to be worth USD 317.1 million in 2025 and anticipated to reach a value of USD 477.7 million by 2035. Sales are projected to rise at a CAGR of 4.3% over the forecast period between 2025 and 2035.
The global vacuum mixing devices market outlook is estimated to be worth USD 169.5 million in 2025 and anticipated to reach a value of USD 214.9 million by 2035. Sales are projected to rise at a CAGR of 2.4% over the forecast period between 2025 and 2035.
The pancreatic stone protein testing market overview is estimated to reach USD 2.2 billion in 2024. It is anticipated to grow at a CAGR of 2.3% during the assessment period 2024 to 2034 and reach a value of USD 2.8 billion by 2034.
The global cardiac surgery devices market strategies is estimated to be worth USD 1.8 billion in 2024 and is projected to grow at a CAGR of 3.7%, reaching USD 2.5 billion by 2034.
The global lacrimal devices market development are estimated to be worth USD 32.1 million in 2025 and anticipated to reach a value of USD 57.0 million by 2035. Sales are projected to rise at a CAGR of 5.9% over the forecast period between 2025 and 2035.
The global knotless tissue control devices market opportunity are estimated to be worth USD 494.4 million in 2025 and are anticipated to reach a value of USD 728.6 million by 2035. Sales are projected to rise at a CAGR of 2.7% over the forecast period between 2025 and 2035.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
